15 June 2017
DETAILS
Blair, Nebraska was chosen as it takes advantage
of Evonik’s decades of operational experience
for large-scale biotechnology operations.
The company has been operating a facility there
for the fermentative production of Biolys®
- the amino acid L-lysine - for almost 20 years.
As an investor and employer Evonik has built
a consistent reputation in the local community.
The new plant will be located adjacent to
Evonik’s current facility on Cargill’s site,
with established access to the raw materials needed
to produce the high value and
pure EPA+DHA omega-3 fatty acid oil.
Both companies announced in March 2017
the start of a joint venture for this purpose.
It will, for the first time, allow for
the production of omega-3 fatty acids for animal nutrition
without using any fish oil from wild caught fish,
a finite resource.
Initial applications will be in salmon aquaculture and pet food.
DSM’s and Evonik’s highly concentrated algal oil
will enable the animal nutrition industry to keep up with
the increasing demand for
these two essential omega-3 fatty acids
without endangering fish stocks, helping to contribute to
healthy animal nutrition as well as
to the ecological balance and biodiversity of the oceans.
Until the facility in Blair opens, DSM
and Evonik
will produce pilot-scale quantities of the algal oil
at DSM’s production facility
in Kingstree, South Carolina (United States).
Customers will be able to receive sizeable quantities
of the product for market development
while the construction
of the new manufacturing plant gets underway.
Contact
For more Information:
Global Director External Communications
Herman Betten
+31 45 578 2017
media.contacts@dsm.com >
Evonik Nutrition & Care GmbH
Jürgen Krauter
+49 6181 50 6847
juergen.krauter@evonik.com >
Contacts
- Evonik Nutrition & Care GmbH
- Dr. Jürgen Krauter
- Head of Communications
- +49 6181 59-6847
- DSM Nutritional Products
- Herman Betten
- Head of Communications
- +31 45 5782017
WWW.CHEMWINFO.COM BY KHUN PHICHAI